Skip to main content

Advertisement

Table 2 Prevalence of primary and multidrug resistance

From: Epidemiology of multidrug-resistant tuberculosis (MDR-TB) in Ethiopia: a systematic review and meta-analysis of the prevalence, determinants and treatment outcome

Studies included Sample size Primary drug resistance % MDR % among
New Re-treated Total Any drug INH RMP New re-treatment over all
Demissie et al. 1997 167 0 167 15.6 8.4 1.8 NR NR 1.2
Gebeyehu, 2001 195 19 195 19.5 7.6 0 NR NR 0.5
Bruchfeld, 2002 103 18 121 14 8.3 2.5 NR NR 0.8
Asmamaw et al., 2008 173 0 173 21.4 13.3 1.2 NR NR 0.6
Meskel et al. 2008 0 84 84 53.6 NR NR NR 26.2 26.2
Agonafir, 2010 44 63 107 60.8 54.2 43.9 2.3 71.4 43
Abate et al., 2012 0 376 376 72.9 56.1 46.5   46.3 46.3
Abebe et al. 2012 136 0 136 18.4 13.2 2.2 1.5 NR 1.5
Tessema et al. 2012 214 46 260 15.8 13.8 5.8 3.7 10.9 5
Yimer et al. 2012 93 0 93 30.1 20.4 3.2 1.1 NR 1.1
Hussein et al. 2013 93 9 102 36.3 29.4 13.7 11.8 11.1 11.8
Biadglegne et al.2014 213 13 226 NR NR NR 1.4 0 1.3
Esmael et al. 2014 165 65 230 33.5 NR NR 1.8 18.5 6.5
Daniel et al. 2014 NR NR 40 NR NR NR 6.3 12.5 7.5
Seyoum et al. 2014 357 0 357 23 14 2.8 1.1 NR 1.1
Tekle et al. 2014 75 12 87 16.5 12.6 2.3 1.3 8.3 2.3
Abdella et al., 2015 79 0 79 58.6 51.4 32.9 NR 31.4 31.4
Adane et al. 2015 77 12 89 20.23 6.74 5.62 1.3 16.7 3.4
Maru et al. 2015 103 15 118 17.8 13.55 0 0 13.3 1.7
Mekonnen et al. 2015 88 36 124 NR NR NR 2.3 13.9 5.6
Ali et al. 2016 NR NR 109 24.77 7.34 5.5 NR NR 3.67
Hamussie et al. 2016 85 21 106 21.7 13.2 7.5 2.4 14.3 4.7
Brhane et al., 2017 67 31 98 18.4 NR 8.2 4.5 22.6 10.2
Weighted mean 31.1 21.65 13.4 2.18* 21.07* 7.24*
Total N 2527 820 3477 3087 2675 2460 2527 820 3477
  1. INH-Isoniazid, RMP-rifampicin, NR = Not reported * value indicates polled prevalence from random effect model